Latest News & Features
Refine Search
Africa
A lack of blood donors and poor healthcare infrastructure inspired Temie Giwa-Tubosun to develop and deliver a life-saving app. LSIPR spoke to the founder of LifeBank. 10 July 2018
Big Pharma
Marie-Paule Kieny of the Drugs for Neglected Diseases Initiative is on a mission to remind stakeholders and governments that there is a moral imperative to pursue the fight against neglected diseases, as she tells LSIPR. 9 July 2018
Europe
A team at the University of Dundee has announced a major breakthrough in the understanding of Parkinson’s disease. LSIPR heard
more from Miratul Muqit and Daan van Aalten of the university’s school of life sciences. 6 July 2018
Africa
Glenda Gray, CEO and president of the South African Medical Research Council, tells LSIPR of the life-saving work she is undertaking and her ambitious goals to improve the South African healthcare landscape. 5 July 2018
Americas
Balancing a company’s duty to shareholders with the public responsibility to provide lifesaving treatments is a constant challenge, as Issi Rozen, chief business officer at the Broad Institute of MIT and Harvard, tells LSIPR. 4 July 2018
Americas
With his interests in IP development, biotechnology innovation policy, and R&D, Luiz Otávio Pimentel, president of Brazil’s patent office, tells LSIPR of his aims to improve the country’s IP performance. 3 July 2018
Europe
Brexit has created many uncertainties in the IP arena and the CEO of the UK Intellectual Property Office is urging stakeholders to speak up, so that the office isn’t the “lone voice” advocating the importance of IP. 2 July 2018
Asia
Speaking to LSIPR Leena Menghaney, regional head of Médecins Sans Frontières’ Access Campaign in South Asia, explains the importance of a balanced IP policy in fostering healthy generic competition. 2 July 2018
Big Pharma
In order to maximise the value from the patent search process, IP practitioners should take note of several tips including offering clear guidance to the searcher—and even saying ‘thank you’. Ellen Sherin of GQ Life Sciences reports. 14 June 2018
Americas
The healthcare industry and governments around the world are turning to precision medicine as an opportunity and a potential saviour. Daniel Lim of Kirkland & Ellis discusses the issues around translating the promise of precision medicine into real world clinical practice. 13 June 2018